Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial.

Autor: Lim AG; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Aas CF; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway., Çağlar ES; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Vold JH; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway., Fadnes LT; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Johansson KA; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Publikováno v: Addiction (Abingdon, England) [Addiction] 2023 Dec; Vol. 118 (12), pp. 2424-2439. Date of Electronic Publication: 2023 Jul 29.